According to studies, downregulation of the PI3K/AKT/mTOR pathway can enhance ferroptosis induction in cancer cells, especially those with PI3K mutations or PTEN deficiency, by downregulating downstream factors such as GPX4, SREBP1, and SLC7A11. This evidence concerns the gene PIK3CG and cancer.